drugset / Trial / NCT06492122
Study With [225Ac]Ac-FL-020 in mCRPC Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, therapeutic effect, and pharmacokinetics of \[225Ac\]Ac-FL-020 in participants with metastatic castration-resistant prostate cancer (mCRPC).
Timeline
- Start
- 2024-08-30
- Primary completion
- 2026-10
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [111In]In-FL-020 | Unknown | — | — |
| Subject | [225Ac]Ac-FL-020 | Unknown | — | Intravenous |